Understanding rare genetic causes of congenital diarrhea in children
Official title: COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
Funded at University of California Los Angeles · NIH-10978459 · Data updated 2026-11-12
This study is looking for the genetic reasons behind congenital diarrhea and enteropathy in kids under 11, so if your child has this condition, researchers want to gather information and samples to help find better ways to understand and diagnose these rare disorders.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | September 15, 2019 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $2,000,000 |
| NIH project number | 2RC2DK118640-06 |
| Project ID | NIH-10978459 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children under 11 years old diagnosed with congenital diarrhea or enteropathy.
✕Less likely to help
Patients with non-genetic causes of diarrhea or those over the age of 11 may not benefit from this research.
What this research studies
This research focuses on identifying the genetic causes of congenital diarrhea and enteropathy (CoDE) in children under 11 years old. By creating a consortium and biorepository, the project aims to collect clinical data and biological samples from affected patients. This will help researchers understand the clinical features and underlying mechanisms of these rare disorders. The study involves a multidisciplinary team of physician-scientists who will analyze patient samples to uncover genetic information and develop new diagnostic tools.
Why it matters
Potential benefit: If successful, this research could lead to better diagnosis and management of congenital diarrhea disorders in children.
How similar studies have gone: Previous research has shown promise in identifying genetic causes of rare disorders, indicating potential success for this approach.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Martin, Martin G — University of California Los Angeles
- Study coordinator: Martin, Martin G
Related research
Other NIH-funded projects on the same topics.
-
PediCODE: A Biorepository and Consortium for CoDE - Congenital Diarrhea and Enteropathy
A nationwide effort to collect clinical data and patient-derived samples to uncover the genetic causes of congenital diarrhea and enteropathy and to build a resource that helps researchers study these diseases.
-
PediCODE Consortium and Biobank for Congenital Diarrhea and Enteropathy
Creating a multi-center team and biobank to find genetic causes of congenital diarrhea and enteropathy in children and collect samples that can help future research.
-
Mobile health tool to guide dehydration care for acute diarrhea across all ages
A mobile app uses AI to help people of all ages determine dehydration risk during acute diarrhea and guide rehydration decisions.
-
Understanding how certain gut bacteria cause diarrhea in children and how it works in the gut lining
This project looks at how infections from ETEC and EPEC bacteria cause diarrhea, especially in children, and uses a mouse model and human-derived gut cell systems to uncover the underlying mechanisms.
-
Targeting a gut transporter to help relieve constipation in CF and older adults
Aimed at helping people with cystic fibrosis and older adults who have chronic constipation by studying a gut transporter to improve intestinal fluid balance.
-
Targeting gut drug processing to prevent diarrhea from mycophenolate
This project tests whether using natural gut-acting compounds to boost a specific drug-clearing pathway in the lower intestine can reduce diarrhea caused by the transplant drug mycophenolate in people who take it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.